seqirus portfolio

United States

Every trademark seqirus holds, newest filings first. The portfolio has 231 marks filed under 12 owner names.

Company overviewGet this data via the API

Search this portfolio

Trademarks on file
231
Active
181
Owner names grouped
12
Portfolio

All trademarks

50 marks per page, newest filing date first. Pick an office to narrow the list.

MarkStatusOfficeClassesFiled
AUJEMFLUpending publicationUSPTO52026-08-14
FLUCLIPSEpending publicationUSPTO52026-08-14
KIGLAFLUpending publicationUSPTO52026-08-14
PHLUDEPZYexaminingUSPTO52026-08-14
PHLUTEKROexaminingUSPTO52026-08-14
PLUZELFLUexaminingUSPTO52026-08-14
RNATEexaminingUSPTO1, 5, 42, 442026-06-22
MULTIPLICITYexaminingUSPTO1, 5, 42, 442026-06-22
MRNATEexaminingUSPTO1, 5, 42, 442026-06-22
IMUEXPANDexaminingUSPTO1, 5, 42, 442026-06-22
AMPLYRNAexaminingUSPTO1, 5, 42, 442026-06-03
MARISAexaminingUSPTO1, 5, 42, 442026-06-03
MAZIEexaminingUSPTO1, 5, 42, 442026-06-03
MIRIAMexaminingUSPTO1, 5, 42, 442026-06-03
MRNACTexaminingUSPTO1, 5, 42, 442026-06-03
RIBOPLUSexaminingUSPTO1, 5, 42, 442026-06-03
XCLEICexaminingUSPTO1, 5, 42, 442026-06-03
CELLJUVANTexaminingUSPTO5, 42, 442026-04-21
CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGYexaminingUSPTO5, 42, 442026-04-21
DURVAXITYpending oppositionUSPTO1, 5, 42, 442026-04-21
ALLYFLUexaminingUSPTO5, 42, 442026-04-17
FLUTOLBYpending oppositionUSPTO52026-04-02
ALLYNZAexaminingUSPTO5, 42, 442026-04-02
ALLYNZA STUDY CELL-BASED ADJUVANT TECHNOLOGYexaminingUSPTO42, 442026-03-02
FLUTEAMallowedUSPTO5, 42, 442026-02-09
FLUPANIONallowedUSPTO5, 42, 442026-02-05
AUJEMFLUregisteredUKIPO52026-02-05
AUJEMFLUregisteredUKIPO52026-02-05
AujemfluregisteredEUIPO52026-02-03
AujemfluregisteredEUIPO52026-02-03
AujemflumixedWIPO52026-01-30
AujemflumixedWIPO52026-01-30
SICKONREPEATexaminingUSPTO442026-01-15
AUJEMFLUexaminingUSPTO52026-01-15
AUJEMFLUexaminingUSPTO52026-01-15
Aujemflu Adjuvanted Cell-based Trivalent Influenza VaccinemixedWIPO52025-10-31
AumixedWIPO52025-10-31
AuregisteredEUIPO52025-09-17
Aujemflu Adjuvanted Cell - based Trivalent Influenza VaccineregisteredEUIPO52025-09-17
AUregisteredUKIPO52025-09-17
AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINEregisteredUKIPO52025-09-17
AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINEallowedUSPTO52025-08-26
AUallowedUSPTO52025-08-25
KOSTAIVEregisteredWIPO52024-02-06
KOSTAIVEregisteredEUIPO52024-01-25
KOSTAIVEregisteredUKIPO52024-01-25
KOSTAIVEallowedUSPTO52024-01-23
IMKOVRUSregisteredWIPO52023-10-31
KEPVERSOregisteredWIPO52023-10-31
KEPVERSOregisteredEUIPO52023-10-25
API

Get this data via the API

Everything on this page comes from the Signa API. Pull seqirus's full portfolio into your own product.

  • GET/v1/entities/{id}/trademarks

    Every trademark in the portfolio, filterable by office and class

  • GET/v1/entities/{id}/analytics

    Portfolio totals, disputes and ownership changes

  • GET/v1/entities/{id}

    Company record, ticker, LEI and owner names

Get API keyView docs
GET /v1/entities/{id}/trademarks
ID=ent_019eb7d7-073e-746b-967e-2a965cfa764c
curl https://api.signa.so/v1/entities/$ID/trademarks \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "object": "list",
  "data": [
    {
      "id": "tm_01a008f9-492d-76be-8e20-4dd1ab47cef9",
      "mark_text": "AUJEMFLU",
      "office_code": "US",
      "status": {
        "stage": "pending_publication"
      },
      "filing_date": "2026-08-14"
    },
    {
      "id": "tm_01a008f9-4995-77f9-8395-ee0f2ebe2521",
      "mark_text": "FLUCLIPSE",
      "office_code": "US",
      "status": {
        "stage": "pending_publication"
      },
      "filing_date": "2026-08-14"
    }
  ],
  "has_more": true
}